Emerging viral diseases;Infections virales émergentes

Bulletin de l'Academie Nationale de Medecine

Volumn 190, Issue 3, 2006, Pages 597-609

  Bricaire, François ^a   Bossi, Philippe ^a   Pene, Pierre ^b   Tubiana, Maurice ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

Arboviruses; Bioterrorism; Communicable diseases; Emerging; Hemorrhagic fevers, viral; Influenza; S v re acute respiratory syndrome

Indexed keywords

ANIMAL; AVIAN INFLUENZA; BIOLOGICAL WARFARE; BIRD; COMMUNICABLE DISEASE; EPIDEMIC ENCEPHALITIS; HUMAN; INFLUENZA; MONKEYPOX; POXVIRUS INFECTION; REVIEW; RISK FACTOR; SEVERE ACUTE RESPIRATORY SYNDROME; SMALLPOX; VIRUS ENCEPHALITIS; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION; WEST NILE FLAVIVIRUS; WORLD HEALTH ORGANIZATION;

ANIMALS; BIOTERRORISM; BIRDS; COMMUNICABLE DISEASES, EMERGING; ENCEPHALITIS, JAPANESE; ENCEPHALITIS, VIRAL; HEMORRHAGIC FEVER, EBOLA; HEMORRHAGIC FEVERS, VIRAL; HUMANS; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MARBURG VIRUS DISEASE; MONKEYPOX; POXVIRIDAE INFECTIONS; RISK FACTORS; SEVERE ACUTE RESPIRATORY SYNDROME; SMALLPOX; VIRUS DISEASES; WEST NILE FEVER; WEST NILE VIRUS; WORLD HEALTH ORGANIZATION;

EID: 33750082720     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33293-5     Document Type: Review

References (24)

1. SAMPATHKUMAR P. - West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention. Mayo Clin. Proc., 2003, 78, 1137-43.
2. Centers for Disease Control and Prevention (CDC) - West Nile virus activity-United States, October 16-22, 2003. MMWR Morb. Mortal. Wkly. Rep., 2003, 52, 1022-3.
3. CARDOSA M. - Emerging arboviral encephalitis. BMJ, 2000, 321, 1484-5.
4. GUBLER D. - Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev., 1998, 11, 480-96.
5. BRAY M., HUGGINS J. - Antiviral therapy of haemorrhagic fevers and arbovirus infections. Antivir Ther., 1998, 3, 53-79.
6. Centers for Disease Control and Prevention: Outbreak of Ebola hemorrhagic fever-Uganda, August 2000-January 2001. Morbidity and Mortality Weekly Report 2000, 50, 73-7.
7. SCHOU S., HANSEN A.K. - Marburg and Ebola virus infections in laboratory non-human primates: a literature review. Comp. Med., 2000, 50, 479-80.
8. Centers for Disease Control and Prevention: Management of patients with suspected viral hemorrhagic fever. Morbidity and Mortality Weekly Report., 1988, 37, S-3, 1-16.
9. Who issues a global alert about cases of atypical pneumonia. Cases of severe respiratory illness may spread to hospital staff. http://www.who.int/csr/ sarsarchives/2003-03-12/en/print.htr
10. DRAZEN J. - Case clusters of the severe acute respiratory syndrome. N. Engl. J. Med., 2003, 348, 6-7.
11. PEIRIS J., LAI S., POON L., GUAN Y., YAM L., LIM W. et al. - Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 2003, 361, 1319-25.
12. DONNELLY C., GHANI A., LEUNG G., HEDLEY A.J., FRASER C., RILEY S. et al. - Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003, 561, 1761-6.
13. LEE N., HUI D., WU A., CHAN P., CAMERON P., JOYNT G.M. et al. - A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med., 2003, 348, 1986-94.
14. TSANG K., HO P, OOI G, YEE W, WANG T, CHAN-YEUNG M. et al. - A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med., 2003, 348, 1977-85.
15. BOOTH C., MATUKAS L., TOMLINSON G., RACHLIS A., ROSE D., DWOSH H. et al. - Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA, 2003, 289, 2801-9.
16. POUTANEN S., Low D., HENRY B., FINKELSTEIN S., ROSE D., GREEN K. et al. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med., 2003, 348, 1995-2005.
17. MARRA M., JONES S., ASTELL C., HOLT R., BROOKS-WILSON A., BUTTERFIELD Y. et al. - The Genome sequence of the SARS-associated coronavirus. Science, 2003, 500, 1399-404.
18. ROTA P.A., OBERSTE M.S., MONROE S.S., Nix W.A., CAMPAGNOLI R., ICENOGLE J. et al. - Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 2003, 500, 1394-9.
19. Centers for Disease Control and Prevention. SARS case fatality ratio, incubation period. http: //www.who.int/csr/sarsarchives/2003-05-07/en/print.htr
20. DERENNE J.P., BRICAIRE F. - Pandémie «la grande menace». Paris: Fayard, 2005, 236 pages.
21. The European Agency for the Evaluation of Medicinal Products/CPMP guidance document on use of medicinal products for treatment and prophylaxis of biological agents that might be used as weapons of bioterrorism. Feb 2002, www.emea.eu.int
22. HENDERSON D., INGLESBY T., BARTLETT J. et al. - Smallpox as a biological weapon. Consensus statement. JAMA, 1999, 281, 2127-37.
23. FRANZ D., JAHRLING P., FRIEDLANDER A. et al. - Clinical recognition and management of patients exposed to biological warfare agents. JAMA, 1997, 278, 399-411.
24. FREY S., COUCH R., TACKET C. et al. - Clinical responses to undiluted and diluted smallpox vaccine. N. Engl. J. Med., 2002, 346, 1265-74.